Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogenetic Hematopoietic Stem Cell Transplantation”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Large-scale testing (Phase 3)Looking for participantsNCT07441291
What this trial is testing

CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

Who this might be right for
B ALLAllogenetic Hematopoietic Stem Cell TransplantationMRD-positive
Peking University People's Hospital 70
Not applicableUnknownNCT05921318
What this trial is testing

Beijing Protocol in Patients Receiving More Than 5/10 HLA-mismatched Allo-HSCT

Who this might be right for
Hematologic MalignancyStem Cell Transplant Complications
Peking University People's Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT05270200
What this trial is testing

Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse

Who this might be right for
Leukemia, Myeloid, Acute
Zhujiang Hospital 40
Testing effectiveness (Phase 2)UnknownNCT02543073
What this trial is testing

MSC for Treatment of Interstitial Lung Disease After Allo-HSCT

Who this might be right for
Lung Diseases, InterstitialHematopoietic Stem Cell TransplantationBronchiolitis Obliterans
Nanfang Hospital, Southern Medical University 60
Not applicableEnded earlyNCT00253552
What this trial is testing

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
OHSU Knight Cancer Institute 4
Large-scale testing (Phase 3)UnknownNCT03662087
What this trial is testing

HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT

Who this might be right for
Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation
Nanfang Hospital, Southern Medical University 100
Post-approval studies (Phase 4)Study completedNCT01335035
What this trial is testing

Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload

Who this might be right for
Iron Overload
Novartis Pharmaceuticals 30
Large-scale testing (Phase 3)Looking for participantsNCT06071637
What this trial is testing

Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT

Who this might be right for
Hematopoietic Stem Cell TransplantationLow-Level Light TherapyStomatitis
Instituto Nacional de Cancer, Brazil 84
Testing effectiveness (Phase 2)UnknownNCT03437603
What this trial is testing

Eltrombopag For Secondary Poor Graft Function Post Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Poor Graft Function
The First Affiliated Hospital of Soochow University 20
Large-scale testing (Phase 3)UnknownNCT03733340
What this trial is testing

Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT

Who this might be right for
Antibacterial ProphylaxisHematological MalignanciesAllogenetic Hematopoietic Stem Cell Transplantation+1 more
Nanfang Hospital, Southern Medical University 250
Large-scale testing (Phase 3)Study completedNCT02673008
What this trial is testing

MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT

Who this might be right for
Minimal Residual DiseaseDonor Lymphocyte InfusionHematopoietic Stem Cell Transplantation+1 more
Nanfang Hospital, Southern Medical University 206
Testing effectiveness (Phase 2)UnknownNCT04692376
What this trial is testing

MSC for Treatment of cGVHD After Allo-HSCT

Who this might be right for
Chronic Graft-versus-host Disease
Nanfang Hospital, Southern Medical University 152